| EDITAS MEDICINE DL-,0001 |
| USA |
| Gesundheit |
| US28106W1036 / A2AC4K |
| 8EM (Frankfurt) / EDIT (NASDAQ) |
| FRA:8EM, ETR:8EM, 8EM:GR, NASDAQ:EDIT |
| - |
| https://www.editasmedicin.. |
|
Editas Medicine Inc. is a pioneering biotechnology company dedicated to transforming healthcare through advanced gene editing technologies. The firm's primary focus is the development of innovative th..
>Volltext.. |
| 159.22 Mio. EUR |
| 85.2 Mio. EUR |
| 39.92 Mio. EUR |
| -97.97 Mio. EUR |
| -172 Mio. EUR |
| -2.05 EUR |
| 67.76 Mio. EUR |
| 142.58 Mio. EUR |
| -154.6 Mio. EUR |
| 2.68 |
| -28.74% |
| 9.95% |
| - |
| - |
| - |
| EDITAS |
| 09.03.26 |
|
||||
|
||||
|